Karsten Spiekermann

Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears

Abstract Acute myeloid leukemia (AML) with IDH1 mutations is amenable to targeted therapy, highlighting the need for reliable identification. We developed an attention-based multiple-instance learning model to predict IDH1 mutation status using bone marrow smear whole-slide image...